CDC: Centre for Disease Control GAVI: Global Alliance for Vaccine Initiatives IDRL: Infectious Disease Research Laboratory IPD: Invasive Pneumococcal Disease PCR: Polymerase Chain Reaction PCV: Pneumococcal Conjugate Vaccine PCV10: 10Valent Pneumococcal Conjugate Vaccine ...
The article discusses a 13-valent pneumococcal conjugate vaccine (PCV13) from Wyeth Pharmaceuticals Inc., which was licensed by the U.S. Food and Drug Administration. The vaccine is used for preventing invasive pneumococcal disease caused by the 13 pneumococcal serotypes covered by the vaccine. ...
Private market use of PCV uses a different schedule (3 + 1) than the NIP (2 + 1). To date, PCV10 has been chosen for the NIP and private market PCV13 use is approximately 30%. 12 Range of vaccine uptake is 49–60%. 13 Australia (non-indigenous) switched from 3 + 0 to 2 +...